See also Factor Xa inhibitors, direct

General information

Otamixaban is direct factor Xa inhibitor [ , ].

Its pharmacokinetics have been studied in healthy men over a wide range of intravenous doses, with durations of administration varying between 1-minute infusions (bolus doses) and 24-hour infusions, using non-compartmental and multicompartmental methods; the half-life was about 0.5 hours [ ].

Drug studies

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here